Neuronetics, inc. (STIM)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
Cash Flows from Operating Activities:
Net loss

-34,128

-29,044

-27,633

-25,727

-26,129

-24,097

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

1,162

1,065

976

876

947

882

0

0

0

Share-based compensation

4,129

3,434

2,837

2,930

2,100

1,743

0

0

0

Non-cash interest expense

1,358

753

752

760

769

839

0

0

0

Change in fair value of convertible preferred stock warrant liability

-

-

-

-

-

1,396

0

0

0

Cost of rental units purchased by customers

266

223

225

227

190

229

0

0

0

Loss on extinguishment of debt

0

-

-

-

-

-

-

-

-

Changes in certain assets and liabilities:
Accounts receivable, net

520

950

2,270

2,112

1,385

1,353

0

0

0

Inventory

469

306

123

139

78

435

0

0

0

Net investments in sales-type leases

2,618

2,610

0

0

0

-

-

-

-

Leasehold reimbursement

0

-

-

-

-

-

-

-

-

Prepaid commission expense

0

-

-

-

0

-

-

-

-

Prepaid expenses and other assets

784

565

-244

-324

-48

237

0

0

0

Accounts payable

475

299

1,210

467

-1,132

606

0

0

0

Accrued expenses

-442

1,549

1,489

1,034

1,818

-52

0

0

0

Deferred revenue

-77

138

636

20

524

-49

0

0

0

Deferred rent

-

-

-

-

-

63

0

0

0

Net Cash Used in Operating Activities

-34,562

-30,482

-26,355

-23,612

-21,864

-20,591

0

0

0

Cash Flows from Investing Activities:
Purchases of property and equipment and capitalized software

805

813

815

896

988

1,011

0

0

0

Net Cash Used in Investing Activities

-805

-813

-815

-896

-988

-1,011

0

0

0

Cash Flows from Financing Activities:
Proceeds from issuance of long-term debt

0

-

-

-

-

-

-

-

-

Repayment of long-term debt

0

-

-

-

-

-

-

-

-

Payments of debt issuance costs

0

-

-

-

-

-

-

-

-

Payments of public offering costs

-

-

-

-

-

3,463

0

0

0

Proceeds from exercises of stock options

1,089

2,420

2,778

2,342

1,879

503

0

0

0

Net Cash Provided by Financing Activities

2,868

2,420

2,780

99,608

98,644

97,038

0

0

0

Net Decrease in Cash and Cash Equivalents

-32,499

-28,875

-24,390

75,100

75,792

75,436

0

0

0

Supplemental disclosure of cash flow information:
Cash paid for interest

3,615

2,949

2,969

2,946

2,895

2,786

0

0

0

Transfer of inventory to property and equipment

-

37

167

141

233

365

0

0

0

Supplemental disclosure of non-cash investing and financing activities:
Purchases of property and equipment and capitalized software in accounts payable and accrued expenses

427

377

0

0

0

-

-

-

-

Deferred initial public offering costs included in accounts payable and accrued expenses

-

-

-

-

-

-

-

0

0